Clinical Trials Browser

Terminated × Lymphoma, Follicular × veltuzumab × Clear all

NCT01147393 2018-02-22

Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma

Phase 1/2 Terminated

4 enrolled 3 charts

Lymphoma, Follicular